Endocannabinoids are extremely frequent in all skin structures. Preliminary data shows that there is an emerging potential of cannabinoids for different indications in dermatology.
In general, there are 3 kinds of cannabinoids: the endocannabinoids occurring in the brain and body, phytocannabinoids in plants like hemp, and synthetic cannabinoids made in the laboratory. “I think the latter are most interesting for medical use because they are designed with a specific purpose, and we will see the best outcomes of them,” said Prof. Adam Friedman (School of Medicine & Health Sciences, USA) .
Cannabinoids address 2 kind of receptors. CB1 is the principal receptor in the central nervous system that regulates transmission of noxious stimuli. Peripherally, it gates the propagation of pain signals. The CB2 receptor is located on immune cells and suppresses the local secretion of pro-inflammatory factors. This receptor is found in the spleen, tonsils, thym...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« How to manage cutaneous side effects of immunotherapy Next Article
Biologics in HS – a growing armamentarium »
Table of Contents: AAD 2020
Psoriasis – What Is Hot?
Systemic Therapies for Dermatologists
Hidradenitis Suppurativa/Acne Inversa
Pearls of the Posters
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.